Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...
1don MSN
Immune sabotage: How a vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and ...
A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...
In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...
The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.
Morning Overview on MSN
Scientists link 2 cancer hallmarks in a way no one expected
Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...
The Phase 1b/2 SCLC trial and Phase 2 VIRO-25 trial are actively enrolling in dose escalation cohorts with an aim to optimize efficacy, safety, and tolerability of Olvi-Vec. The trials are being ...
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback